Early detection is key. Bone Densitometry (DEXA) is an advanced technology that safely, accurately and painlessly measures bone density and mineral content of the spine, hip, and wrist in order to determine the risk of developing osteoporosis. Approximately 50% of women over age 50 are at risk of sustaining an osteoporotic fracture.

Considered the most reliable measurement of bone density, DEXA scans are used for both assessment of risk and for follow-up serial measurements.

With DEXA, doctors are better equipped to detect and treat bone loss in its earliest stages, so as to prevent the disease or lessen its impact. During a comprehensive DEXA evaluation, Bone Mineral Density (BMD) is calculated and compared to normal BMD values, matched for age and gender, to confirm or exclude osteoporosis. A low BMD may predict the likelihood of developing osteoporosis and can help determine a proactive treatment plan.

Osteoporosis Risk Factors

• Female, Post-menopausal
• Tobacco use
• Alcoholism
• Poor nutrition
• Sedentary lifestyle
• Family history
• Race and ethnicity
• Certain medications
• Certain diseases

What Do Your Results Mean?
The results of your DEXA study will be classified into one of three categories.

• Normal bone mass: A repeat study is suggested in 3 to 5 years to evaluate new bone loss.
• Osteopenia: Low bone mass; repeat the screening in one year to determine progression toward osteoporosis.
• Osteoporosis: The patient may be at increased risk for fracture. Consult your primary care physician; repeat study in one year to evaluate effects of therapy or progression of bone loss.